Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

SYNTAX creates common ground for coronary risk assessment

Sep. 3, 2010

Guidelines praise new tech, but give stents short shrift

Sep. 2, 2010

GE unit sees $1 billion opportunity in healthcare reform market

Sep. 1, 2010

German IVD for cervical cancer aims to disrupt U.S. market

Aug. 23, 2010

Report from Europe: GE unit sees $1B opportunity in healthcare reform market

Aug. 4, 2010

Tale of two citations:Value of med-tech depends on agenda

Aug. 1, 2010

Report from Europe: Micro-optimism detected among nano manufacturers

July 22, 2010

Report from Europe: Tale of two citations: Value of med-tech depends on agenda

July 21, 2010

Report from Europe: IPO for Carmat's artificial heart exceeds expectations

July 9, 2010

Compelling registry results help to clinch clinical case for TAVI

July 1, 2010

View All Articles by John Brosky

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...